slotkoers
Ho Chi Minh S.E.
00:00:00 06-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
65.800
VND
|
-2,37%
|
|
-1,20%
|
+14,43%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
2.621.924
|
2.500.377
|
2.059.339
|
1.823.192
|
1.427.299
|
1.996.829
|
Bedrijfswaarde
1 |
2.275.913
|
2.141.711
|
1.826.569
|
1.512.572
|
974.595
|
1.407.268
|
K/w-verhouding
|
11,5
x
|
10,7
x
|
11,5
x
|
11,4
x
|
7,13
x
|
12,8
x
|
Dividendrendement
|
3,31%
|
3,47%
|
4,22%
|
4,76%
|
6,08%
|
-
|
Marktkapitalisatie/omzet
|
1,89
x
|
1,7
x
|
1,42
x
|
1,22
x
|
0,9
x
|
1,16
x
|
Bedrijfswaarde/omzet
|
1,64
x
|
1,46
x
|
1,26
x
|
1,01
x
|
0,61
x
|
0,82
x
|
Bedrijfswaarde/EBITDA
|
7,76
x
|
7,25
x
|
7,98
x
|
7,19
x
|
3,84
x
|
6,96
x
|
Bedrijfswaarde/FCF
|
-22,7
x
|
42,8
x
|
-29,4
x
|
10,8
x
|
4
x
|
10
x
|
FCF Yield
|
-4,4%
|
2,34%
|
-3,4%
|
9,25%
|
25%
|
9,97%
|
Price to Book
|
2,32
x
|
2
x
|
1,57
x
|
1,33
x
|
0,98
x
|
1,31
x
|
Aantal aandelen (in duizenden)
|
34.727
|
34.727
|
34.727
|
34.727
|
34.727
|
34.727
|
Referentieprijs
2 |
75.500
|
72.000
|
59.300
|
52.500
|
41.100
|
57.500
|
Datum van publicatie
|
18-03-19
|
30-03-20
|
31-03-21
|
01-04-22
|
03-04-23
|
02-04-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
1.385.088
|
1.468.390
|
1.451.954
|
1.498.395
|
1.592.727
|
1.719.032
|
EBITDA
1 |
293.328
|
295.232
|
228.776
|
210.337
|
253.970
|
202.211
|
Bedrijfsresultaat (EBIT)
1 |
263.924
|
266.947
|
203.176
|
186.405
|
234.484
|
183.443
|
Operationele Marge
|
19,05%
|
18,18%
|
13,99%
|
12,44%
|
14,72%
|
10,67%
|
Resultaat voor belastingen (EBT)
1 |
286.090
|
290.916
|
224.566
|
199.204
|
250.198
|
229.175
|
Nettowinst (verlies)
1 |
228.772
|
232.635
|
179.535
|
159.282
|
200.076
|
183.333
|
Nettomarge
|
16,52%
|
15,84%
|
12,37%
|
10,63%
|
12,56%
|
10,66%
|
WPA
2 |
6.588
|
6.699
|
5.170
|
4.587
|
5.761
|
4.487
|
Free Cash Flow
1 |
-100.216
|
50.029
|
-62.098
|
139.874
|
243.514
|
140.283
|
FCF-marge
|
-7,24%
|
3,41%
|
-4,28%
|
9,33%
|
15,29%
|
8,16%
|
Kasstroomconversie (ebitda)
|
-
|
16,95%
|
-
|
66,5%
|
95,88%
|
69,37%
|
Kasstroomconversie (nettowinst)
|
-
|
21,51%
|
-
|
87,82%
|
121,71%
|
76,52%
|
Dividend per aandeel
2 |
2.500
|
2.500
|
2.500
|
2.500
|
2.500
|
-
|
Datum van publicatie
|
18-03-19
|
30-03-20
|
31-03-21
|
01-04-22
|
03-04-23
|
02-04-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
346.011
|
358.667
|
232.770
|
310.620
|
452.704
|
589.561
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-100.216
|
50.029
|
-62.098
|
139.874
|
243.514
|
140.283
|
ROE (netto-inkomsten/eigen vermogen)
|
22%
|
19,5%
|
14%
|
11,9%
|
14,2%
|
12,3%
|
ROA (netto-inkomsten/totale activa)
|
11,9%
|
11,1%
|
8,47%
|
7,55%
|
8,47%
|
6,22%
|
Totale activa
1 |
1.921.256
|
2.090.214
|
2.118.659
|
2.109.470
|
2.361.725
|
2.947.946
|
Nettoactief per aandeel
2 |
32.526
|
36.060
|
37.877
|
39.336
|
42.028
|
43.784
|
Cashflow per aandeel
2 |
2.289
|
2.833
|
3.096
|
2.458
|
1.367
|
3.292
|
Capex
1 |
41.930
|
35.203
|
14.258
|
6.114
|
10.565
|
7.301
|
Capex/omzet
|
3,03%
|
2,4%
|
0,98%
|
0,41%
|
0,66%
|
0,42%
|
Datum van publicatie
|
18-03-19
|
30-03-20
|
31-03-21
|
01-04-22
|
03-04-23
|
02-04-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +14,43% | 89,95 mln. | | +33,43% | 700 mld. | | +26,43% | 569 mld. | | -5,12% | 358 mld. | | +19,59% | 330 mld. | | +4,89% | 287 mld. | | +14,32% | 236 mld. | | +5,79% | 202 mld. | | -9,49% | 197 mld. | | +4,26% | 161 mld. |
Farmaceutische producten - Andere
|